S-amlodipine

DRUG3 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Hypertension

Phase 1

CKD-828 (80/5mg) Pharmacokinetic Study

CompletedNCT02250833

Chong Kun Dang PharmaceuticalHypertension

Start: 2014-09-30End: 2014-12-31Updated: 2015-04-10

CKD-828 (80/5mg) Pharmacokinetic Study

CompletedNCT02358824

Chong Kun Dang PharmaceuticalHypertension

Start: 2015-02-28End: 2015-06-30Updated: 2015-07-08

Phase 2

CKD-828 Primary Hypertension Trial(Dose-selection)

CompletedNCT01128322

Chong Kun Dang PharmaceuticalHypertension

Start: 2010-07-31End: 2011-03-31Target: 430Updated: 2011-04-26